Who is the CEO of Banyan Corp.?

Mr. Michael J. Gelmon LL.B. is a business executive who currently serves as the CEO of Banyan Corp..

What is the Revenue Growth of Banyan Corp.?

Revenue growth data for Banyan Corp. is currently unavailable.

What is Banyan Corp. operating Margin?

Banyan Corp. operating margin is -31.85% which shows how much profit BNYN earns from each dollar of sales, after subtracting the direct costs tied to generating that revenue.

In which market sector does Banyan Corp. operate?

Banyan Corp. falls under the Healthcare sector which thrives across multiple industries. It stays competitive through its diverse product lineup, which spans computer hardware, tech gadgets, video streaming services, and cloud computing solutions.

What is Banyan Corp. revenue growth?

Revenue growth data for Banyan Corp. is currently unavailable.

Banyan Corp.

BNYN•PNK

HealthcareMedical - Care Facilities

$0.00

$0.00(0.00%)

Banyan Corp. (BNYN) Stock Overview

Explore Banyan Corp.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for BNYNStats details for BNYN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations data is not available for BNYNAnalyst Recommendations details for BNYN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.

CEO

Mr. Michael J. Gelmon LL.B.

Employees

Headquarters

9025 Wilshire Boulevard, Beverly Hills, CA

Founded

2002